Arellano-Rodrigo E - Search Results

1

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Arellano-Rodrigo E, López-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F. Arellano-Rodrigo E, et al. Eur J Haematol. 2003 Apr;70(4):219-24. doi: 10.1034/j.1600-0609.2003.00045.x. Eur J Haematol. 2003. PMID: 12656744

2

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia.

Alvarez-Larrán A, Cuevas B, Velez P, Noya S, Caballero-Navarro G, Ferrer-Marín F, Carbonell S, Pérez-Encinas M, Gómez-Casares MT, Pérez-López R, Magro E, Moretó A, Pastor-Galán I, Angona A, Mata-Vázquez MI, Guerrero-Fernández L, Guerra JM, Carreño-Tarragona G, Fox L, Murillo I, García-Gutiérrez V, Mora E, Stuckey R, Arellano-Rodrigo E, Hernández-Boluda JC, Pereira A. Alvarez-Larrán A, et al. Among authors: arellano rodrigo e. Hemasphere. 2023 Jul 18;7(8):e936. doi: 10.1097/HS9.0000000000000936. eCollection 2023 Aug. Hemasphere. 2023. PMID: 37476303 Free PMC article.

3

Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.

Hernández-Boluda JC, Carreras E, Cervantes F, Marín P, Arellano-Rodrigo E, Rovira M, Solé F, Lloveras E, Espinet B, Ocejo A, Montserrat E. Hernández-Boluda JC, et al. Haematologica. 2002 Jan;87(1):17-22. Haematologica. 2002. PMID: 11801461

4

Fingertip cellulitis after fingerstick for capillary microhematocrit measurement in a patient with chronic lymphocytic leukemia: an uncommom infectious complication.

Arellano-Rodrigo E, Rovira M, Cibeira MT, Abelló D, Montserrat E. Arellano-Rodrigo E, et al. Haematologica. 2002 Dec;87(12):ECR39. Haematologica. 2002. PMID: 12495910 No abstract available.

5

Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.

Cervantes F, Alvarez-Larrán A, Domingo A, Arellano-Rodrigo E, Montserrat E. Cervantes F, et al. Br J Haematol. 2005 Jun;129(6):771-5. doi: 10.1111/j.1365-2141.2005.05524.x. Br J Haematol. 2005. PMID: 15953003 Free article.

6

Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution.

Cervantes F, Alvarez-Larrán A, Arellano-Rodrigo E, Granell M, Domingo A, Montserrat E. Cervantes F, et al. Leukemia. 2006 Jan;20(1):55-60. doi: 10.1038/sj.leu.2404048. Leukemia. 2006. PMID: 16307011

7

Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia.

Muntañola A, Bosch F, Arguis P, Arellano-Rodrigo E, Ayuso C, Giné E, Crespo M, Abrisqueta P, Moreno C, Cobo F, López-Guillermo A, Montserrat E. Muntañola A, et al. J Clin Oncol. 2007 Apr 20;25(12):1576-80. doi: 10.1200/JCO.2006.08.4194. Epub 2007 Mar 12. J Clin Oncol. 2007. PMID: 17353549

8

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

Hernández-Boluda JC, Pastor-Galán I, Arellano-Rodrigo E, Raya JM, Pérez-Encinas M, Ayala R, Ferrer-Marín F, Velez P, Mora E, Fox ML, Hernández-Rivas JM, Xicoy B, Mata-Vázquez MI, García-Fortes M, Pérez-López R, Angona A, Cuevas B, Senín A, Ramírez MJ, Ramírez-Payer A, Gómez-Casares MT, Martínez-Valverde C, Magro E, Steegmann JL, Durán MA, García-Hernández C, Gasior M, de Villambrosia SG, Alvarez-Larrán A, Pereira A; Spanish MPN Group (GEMFIN). Hernández-Boluda JC, et al. Br J Haematol. 2022 Nov;199(4):529-538. doi: 10.1111/bjh.18440. Epub 2022 Sep 12. Br J Haematol. 2022. PMID: 36089912

9

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.

Martínez-Trillos A, Gaya A, Maffioli M, Arellano-Rodrigo E, Calvo X, Díaz-Beyá M, Cervantes F. Martínez-Trillos A, et al. Ann Hematol. 2010 Dec;89(12):1233-7. doi: 10.1007/s00277-010-1019-9. Epub 2010 Jun 22. Ann Hematol. 2010. PMID: 20567824

10

Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study.

Alvarez-Larrán A, Pereira A, Arellano-Rodrigo E, Hernández-Boluda JC, Cervantes F, Besses C. Alvarez-Larrán A, et al. Br J Haematol. 2013 Jun;161(6):865-71. doi: 10.1111/bjh.12321. Epub 2013 Apr 12. Br J Haematol. 2013. PMID: 23577924 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters